title: Two-dimensional infrared spectroscopy provides evidence of an intermediate in the membrane-catalyzed assembly of diabetic amyloid.
abstract: Islet amyloid polypeptide (IAPP, also known as amylin) is responsible for pancreatic amyloid deposits in type 2 diabetes. The deposits, as well as intermediates in their assembly, are cytotoxic to pancreatic beta-cells and contribute to the loss of beta-cell mass associated with type 2 diabetes. The factors that trigger islet amyloid deposition in vivo are not well understood, but peptide membrane interactions have been postulated to play an important role in islet amyloid formation. To better understand the role of membrane interactions in amyloid formation, two-dimensional infrared (2D IR) spectroscopy was used to compare the kinetics of amyloid formation for human IAPP both in the presence and in the absence of negatively charged lipid vesicles. Comparison of spectral features and kinetic traces from the two sets of experiments provides evidence for the formation of an ordered intermediate during the membrane-mediated assembly of IAPP amyloid. A characteristic transient spectral feature is detected during amyloid formation in the presence of vesicles that is not observed in the absence of vesicles. The spectral feature associated with the intermediate raises in intensity during the self-assembly process and subsequently decays in intensity in the classic manner of a kinetic intermediate. Studies with rat IAPP, a variant that is known to interact with membranes but does not form amyloid, confirm the presence of an intermediate. The analysis of 2D IR spectra in terms of specific structural features is discussed. The unique combination of time and secondary structure resolution of 2D IR spectroscopy has enabled the time-evolution of a hIAPP intermediate to be directly monitored for the first time. The data presented here demonstrates the utility of 2D IR spectroscopy for studying membrane-catalyzed amyloid formation.
authors.affiliation: Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706-1396, USA.
authors.forename: Yun L
authors.initials: YL
authors.lastname: Ling
authors.forename: David B
authors.initials: DB
authors.lastname: Strasfeld
authors.forename: Sang-Hee
authors.initials: SH
authors.lastname: Shim
authors.forename: Daniel P
authors.initials: DP
authors.lastname: Raleigh
authors.forename: Martin T
authors.initials: MT
authors.lastname: Zanni
mesh_terms: D000682:Amyloid / Q000737:chemistry*; D000818:Animals; D002384:Catalysis; D006801:Humans; D058228:Islet Amyloid Polypeptide; D008055:Lipids / Q000737:chemistry; D009682:Magnetic Resonance Spectroscopy; D051381:Rats; D053835:Unilamellar Liposomes / Q000737:chemistry*
chemical_list: D000682:Amyloid; D058228:Islet Amyloid Polypeptide; D008055:Lipids; D053835:Unilamellar Liposomes